Active substance
Results for the substance entrectinib
3 results
About this active substance
Entrectinib is an innovative medication used to treat certain types of cancer, especially solid tumors with specific rare genetic mutations. It works by blocking specific proteins involved in the growth and spread of cancer cells. Entrectinib is usually taken as tablets, as directed by the oncologist.
During treatment with entrectinib, close monitoring of health status is necessary, as side effects or unexpected reactions may occur. Patients should strictly follow the treatment schedule and report any new symptoms to their doctor.
Side effects may include fatigue, nausea, dizziness, constipation, weight gain, or changes in taste. In rare cases, severe allergic reactions or impaired heart function may occur.
Entrectinib is an important option for patients with certain types of cancer, but it requires constant medical supervision to ensure the effectiveness and safety of the treatment. Collaboration with the medical team is essential for therapy success.
During treatment with entrectinib, close monitoring of health status is necessary, as side effects or unexpected reactions may occur. Patients should strictly follow the treatment schedule and report any new symptoms to their doctor.
Side effects may include fatigue, nausea, dizziness, constipation, weight gain, or changes in taste. In rare cases, severe allergic reactions or impaired heart function may occur.
Entrectinib is an important option for patients with certain types of cancer, but it requires constant medical supervision to ensure the effectiveness and safety of the treatment. Collaboration with the medical team is essential for therapy success.
-
-
ROZLYTREK 100mg capsules EGIS ORIGINAL MEDICINE
-
ROZLYTREK 50mg film-coated granules in sachet EGIS ORIGINAL MEDICINE